Profile
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Former positions of Nathalie Riebel
| Companies | Position | End |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 01/12/2023 |
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/03/2011 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | - |
| GSK PLC | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| GSK PLC | Health Technology |
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Private companies | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Nathalie Riebel
